espada 20mg f.c tablets film-coated tablet
ms pharma saudi (msps), saudi arabia - memantine hydrochloride - film-coated tablet - 20 mg
zeimer 10mg f.c.tablet film-coated tablet
deef pharmaceutical industries, saudi arabia - memantine hydrochloride - film-coated tablet - 10 mg
memantine-mppl memantine hydrochloride 20mg film-coated tablet blister pack
lupin australia pty limited - memantine hydrochloride -
memantine-mppl memantine hydrochloride 15mg film-coated tablet blister pack
lupin australia pty limited - memantine hydrochloride -
memantine-mppl memantine hydrochloride 10mg film-coated tablet blister pack
lupin australia pty limited - memantine hydrochloride -
memantine-mppl memantine hydrochloride 5mg film-coated tablet blister pack
lupin australia pty limited - memantine hydrochloride -
memantine merz
merz pharmaceuticals gmbh - memantine hydrochloride - alzheimer disease - other anti-dementia drugs - treatment of patients with moderate to severe alzheimer’s disease.
memantine mylan
mylan pharmaceuticals limited - memantine hydrochloride - alzheimer disease - other anti-dementia drugs, psychoanaleptics, - treatment of patients with moderate to severe alzheimer’s disease.
memantine hydrochloride- memantine tablet, film coated
amneal pharmaceuticals of new york llc - memantine hydrochloride (unii: jy0wd0ua60) (memantine - unii:w8o17sjf3t) - memantine hydrochloride 5 mg - memantine hydrochloride tablets are indicated for the treatment of moderate to severe dementia of the alzheimer’s type. memantine hydrochloride tablets are contraindicated in patients with known hypersensitivity to memantine hydrochloride or to any excipients used in the formulation. risk summary there are no adequate data on the developmental risk associated with the use of memantine hydrochloride in pregnant women. adverse developmental effects (decreased body weight, and skeletal ossification) were observed in the offspring of rats administered memantine during pregnancy at doses associated with minimal maternal toxicity. these doses are higher than those used in humans at the maximum recommended daily dose of memantine hydrochloride [see data] . in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively. the background risk of major birth defects and miscarriage for the indicated populat
reminyl 4mg film-coated tablets
janssen-cilag international nv turnhoutseweg 30, b-2340 beerse, belgium - galantamine - film-coated tablet - galantamine - psychoanaleptics